MENU

SPRO Stock Tickeron detected bullish Stock Pattern: Broadening Bottom SPRO on May 27, 2025, netting in a 5.28% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+5.28% Gain from a Successful pattern Broadening Bottom
SPRO - Spero Therapeutics
Tickeron
Ticker: SPRO
Company: Spero Therapeutics
Gain: +5.28%
Confirmed: 05/27/25
Succeeded: 05/27/25
Total length: 57 days
On March 31, 2025, A.I.dvisor detected a Broadening Bottom Pattern (Bullish) for Spero Therapeutics (SPRO, $0.72). On May 27, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $1.08. On May 27, 2025, SPRO reached the target price resulting in a for traders who took a long position in the stock.

Aroon Indicator for SPRO shows an upward move is likely

SPRO's Aroon Indicator triggered a bullish signal on June 24, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 119 similar instances where the Aroon Indicator showed a similar pattern. In of the 119 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

SPRO moved above its 50-day moving average on May 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SPRO crossed bullishly above the 50-day moving average on May 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for SPRO moved above the 200-day moving average on June 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRO advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SPRO moved out of overbought territory on June 24, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for SPRO turned negative on June 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SPRO broke above its upper Bollinger Band on May 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SPRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.796) is normal, around the industry mean (16.515). P/E Ratio (10.751) is within average values for comparable stocks, (59.269). SPRO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (5.583) is also within normal values, averaging (253.659).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com